stars 1 stars 2 stars 3

Pinnacle Transplant Technologies is a tissue processor and contract manufacturing organization committed to honoring the gift of donation and improving patients' quality of life through the processing and distribution of high-quality allograft implants. We offer a comprehensive allograft portfolio, and private-label and custom allografts across multiple market segments, including Spine, Wound Care, Orthopedics, Sports Medicine, Trauma, and Dental. For over a decade, Pinnacle has helped surgeons improve the lives of thousands of patients. Pinnacle is registered with the U.S. Food and Drug Administration (FDA), accredited by the Association for Advancing Tissue and Biologics (AATB), and maintains all applicable state licenses. Safety and quality are our priority. We partner with tissue recovery organizations across the U.S. to acquire donated tissue and are committed to delivering quality customer service and solutions to our partners, customers, and healthcare professionals.

Pinnacle Transplant Technologies Questions

The Pinnacle Transplant Technologies annual revenue was $15.6 million in 2026.

Roger Rose is the President and Chief Executive Officer of Pinnacle Transplant Technologies.

67 people are employed at Pinnacle Transplant Technologies.

Pinnacle Transplant Technologies is based in Phoenix, Arizona.

The NAICS codes for Pinnacle Transplant Technologies are [621, 62199, 62, 6219, 621991].

The SIC codes for Pinnacle Transplant Technologies are [80, 809].

Top Pinnacle Transplant Technologies Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users